SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 31 Oct 2024
Last Applicant/ Owned by
2-9 Kanda-Tsukasamachi
Chiyoda-ku, Tokyo
JP
101-8535
Serial Number
86939709 filed on 14th Mar 2016
Registration Number
5492665 registered on 12th Jun 2018
Correspondent Address
Scott S. Havlick
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
DA
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient
First Use Date in General
01st Dec 2017
First Use Date in Commerce
01st Dec 2017
Mark Details
Serial Number
No 86939709
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 57182.0274
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Oct 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 31st Oct 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 31st Oct 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 09th May 2024 | TEAS SECTION 8 & 15 RECEIVED |
| 12th Jun 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 12th Jun 2018 | REGISTERED-PRINCIPAL REGISTER |
| 10th May 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th May 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 16th Apr 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 16th Apr 2018 | STATEMENT OF USE PROCESSING COMPLETE |